Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
See Latest ArticlesEfalizumab discontinuation: A practical strategy
Journal of Dermatological Treatment , 05/21/09
Pugashetti R et al. - Efalizumab is a recombinant, humanized IgG1 monoclonal antibody used in the treatment of plaque psoriasis. Efalizumab specifically targets T cells, leading to the subsequent inhibition of T-cell activation.
Related Articles
Cutaneous Lupus Erythematosus: Issues in Diagnosis and Treatment
American Journal of Clinical Dermatology, 10/20/09
Relevance Score: 80%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Pharmacotherapy of regional melanoma therapy
Expert Opinion in Pharmacotherapy, 12/14/09
Dapsone hypersensitivity syndrome in non-leprosy patients: A retrospective study of its incidence in a tertiary referral center in Taiwan
Journal of Dermatological Treatment , 12/11/09
Muscle Weakness After Repeated Injection of Botulinum Toxin Type A Evaluated According to Bite Force Measurement of Human Masseter Muscle
Dermatologic Surgery, 12/10/09
Today in Psoriasis...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial
Archives of Drug Information, 12/08/09
Analysis of psoriatic patients registered in Asahikawa Medical College Hospital from 1983 to 2007
Journal of Dermatology, 12/08/09
Modulation of extracellular matrix through keratinocyte-fibroblast crosstalk
Expert Review of Dermatology, 12/08/09
Sponsor
Article Search
Sponsor
Sponsor